SUBSCRIBE
SUBSCRIBE

Cambridge Heart’s Alternans Test Gains Additional Reimbursement Acceptance; CareFirst Blue Cross/Blue Shield Issues Medical Policy For MTWA Testing

October 19, 2005 | 
1 min read

Cambridge Heart, Inc. (OTCBB: CAMH) today announced that CareFirst Blue Cross/Blue Shield has issued a medical policy providing coverage of its Microvolt T-Wave Alternans (MTWA) Test.